Trifarotene
1 NDC across 1 manufacturer|0 Generic,1 Brand
Trifarotene is used to treat acne vulgaris, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 4, 2019. In 2024, Medicare Part D spent $260K on Trifarotene across 373 claims for 186 beneficiaries.
Trifarotene is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $16.36 to $16.36 per GM. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$16.36 – $16.36
per GM
7d Activity
avg +0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing TRIFAROTENE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AKLIEF 0.005% CREAM | $16.3632 per GM | +0.09% |
Frequently Asked Questions
What is Trifarotene used to treat?
Trifarotene is used to treat acne vulgaris, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Trifarotene?
In 2024, Medicare Part D spent $260K on Trifarotene across 373 claims for 186 beneficiaries.
How many Trifarotene products are on the market?
The Trifarotene drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Trifarotene?
NADAC reference prices for Trifarotene range from $16.3632 to $16.3632 per GM.
Which manufacturers make Trifarotene?
1 manufacturer lists Trifarotene in NADAC. Ranked by number of NDCs, the largest are Galderma Laboratories, L.P. (1).
How has the price of Trifarotene changed recently?
Over the past 7 days, 1 Trifarotene NDC rose and 0 fell, with a market-wide average change of +0.1%.